KEY POINTS
- This single-center Australian cross-sectional study assessed anxiety immediately before thermoplastic mask fabrication for head and neck radiotherapy. Between January and November 2020, 39 of 42 eligible patients (93%) consented to participate. Mean age was 65.2 years, 74% were men, and 90% received radical-intent treatment. Patients completed a 10-item questionnaire containing the validated six-item State-Trait Anxiety Inventory (STAI Y-6) and four study-specific questions.
- Clinically meaningful state anxiety was present in 17/39 patients (44%; 95% CI 29–59%), using a prorated STAI Y-6 threshold of ≥41. Mean anxiety score was 43.3 ± 14.1, with a median of 40. A more stringent threshold of ≥55, indicating severe situational anxiety, was reached by 8/39 patients (21%; 95% CI 11–36%). The prevalence estimate is imprecise because of the small sample size.
- Brief anxiety assessment was feasible during routine radiotherapy preparation. All 39 patients completed every questionnaire item, giving a 100% completion rate, with a median completion time of 3.6 minutes (IQR 1.7–6.3). Twenty-six patients (67%) completed the questionnaire within five minutes, and no adverse effects or distress from completing the questionnaire were reported. These findings demonstrate administrative feasibility rather than proven benefit from screening.
- Higher STAI Y-6 scores were associated with greater self-reported mask-specific anxiety. Among patients meeting the ≥41 threshold, 71% reported at least some anxiety about mask fabrication, compared with 32% below the threshold (p=0.025). In contrast, general anxiety about receiving radiotherapy was not significantly associated with STAI classification (p=0.41). These findings suggest that the instrument may identify patients distressed by immobilization, although the additional mask-specific questions were not formally validated.
- Interest in virtual reality (VR) rehearsal was mixed and did not clearly increase with anxiety severity. Overall, 16/39 patients (41%) wanted a guided VR preparation session, 16 (41%) declined, and seven (18%) were uncertain. The proportion expressing definite interest was 41% in both anxiety groups. The significant association with anxiety classification (p=0.027) was driven by greater uncertainty among anxious patients (35% vs 5%), rather than stronger expressed demand for VR.
- The study did not evaluate whether VR or another intervention actually reduced anxiety. Most participants either doubted or were unsure whether guided VR would help, and the questionnaire was administered only once, immediately before simulation. Consequently, the investigation could not determine whether anxiety persisted during treatment, affected immobilization accuracy, increased treatment interruptions, or responded to preparatory interventions.
- Interpretation is limited by the 39-patient single-center sample, lack of repeated assessments, exclusion of patients unable to complete English-language questionnaires, and use of a general state-anxiety instrument rather than a validated mask-specific scale. Importantly, recruitment occurred during 2020, when COVID-19-related distress may have influenced results. The findings may not reflect contemporary practice involving more widespread open-face masks, preparatory resources, and psycho-oncology support.
CLINICAL TAKEAWAY
Clinically meaningful anxiety may be common immediately before head and neck radiotherapy mask fabrication, and a short patient-reported screening questionnaire appears feasible within routine simulation appointments. However, this small observational study does not establish that screening improves treatment tolerance or that virtual reality reduces mask-related distress, supporting further prospective evaluation of targeted preparation pathways.